BlackRock’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $6.84M | Sell |
|
|||||
|
2024
Q4 | $8.49M | Sell |
|
|||||
|
2024
Q3 | $19M | Buy |
|
|||||
|
2024
Q2 | $19.6M | Sell |
|
|||||
|
2024
Q1 | $31M | Sell |
|
|||||
|
2023
Q4 | $27.7M | Buy |
|
|||||
|
2023
Q3 | $19.7M | Buy |
|
|||||
|
2023
Q2 | $41.6M | Buy |
|
|||||
|
2023
Q1 | $29.1M | Buy |
|
|||||
|
2022
Q4 | $42.2M | Buy |
|
|||||
|
2022
Q3 | $86M | Buy |
|
|||||
|
2022
Q2 | $65.2M | Buy |
|
|||||
|
2022
Q1 | $39.4M | Buy |
|
|||||
|
2021
Q4 | $15.5M | Buy |
|
|||||
|
2021
Q3 | $21.1M | Buy |
|
|||||
|
2021
Q2 | $4.02M | Buy |
|